Clinical Trial Update: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO [NA]

View source ↗

Summary

An extension study assessing the safety and tolerability of Ranibizumab in subjects with choroidal neovascularization related to age-related macular degeneratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization
• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Choroidal Neovascularization, Age-related Macular Degeneration | NA | Status: COMPLETED | Results posted: 2012-01-13